Autoinflammatory and autoimmune 2 Flashcards

1
Q
  1. Describe the pathophysiology of Graves’ disease.
A

Excessive production of thyroid hormones mediated by IgG antibodies that stimulate the TSH receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Which antibodies is Hashimoto’s thyroiditis associated with?
A

Anti-TPO antibodies

Anti-thyroglobulin antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. What histological feature has been observed in the pancreas of non-obese diabetic mice?
A

CD8+ T cell infiltration of the pancreas

The CD8+ T cells bind to peptides presented by MHC Class I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. List some autoantibodies that are found in type I diabetes mellitus.
A

Anti-GAD
Anti-IA2
Anti-islet cell
Anti-insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Outline the pathophysiology of pernicious anaemia.
A

Patients develop antibodies against intrinsic factor which leads to failure of absorption of vitamin B12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. What is a major complication of vitamin B12 deficiency?
A

Subacute degeneration of the spinal cord (involved the posterior and lateral columns)
NOTE: other neurological features include peripheral neuropathy and optic neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. Which antibodies are useful in the diagnosis of pernicious anaemia?
A

Anti-parietal cell antibodies

Anti-intrinsic factor antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. Outline the pathophysiology of myasthenia gravis.
A

Patients develop antibodies against nicotinic acetylcholine receptors leading to failure of depolarisation of the motor endplate
Myasthenia gravis is characterised by fluctuating weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Which investigations may be used in the diagnosis of myasthenia gravis?
A

EMG studies are usually abnormal
Tensilon test – administer very short-acting acetylcholinesterase (e.g. edrophonium bromide) which causes a rapid improvement in symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. List some genetic polymorphisms that predispose to rheumatoid arthritis.
A
HLA DR1
HLA DR4
PTPN22
PAD 2 and PAD 4 polymorphisms
Polymorphisms affecting TNF, IL1, IL6 and IL10
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. What is a key common feature amongst HLA alleles that are associated with rheumatoid arthritis?
A

They share a sequence at position 70-74 of the HLA DR-beta chain (shared epitope)
This enables binding of HLA to arthritogenic peptides (particularly citrullinated peptides)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. Describe the role of PAD in the pathogenesis of rheumatoid arthritis.
A
Peptidylarginine deaminases (2 and 4) are involved in the deamination of arginine to form citrulline 
Polymorphisms that are associated with increased citrullination leads to a high load of citrullinated peptides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. List some environmental factors that contribute to the pathogenesis of rheumatoid arthritis.
A

Smoking is associated with the development of erosive disease (due to increased citrullination)
Gum infection by Porphyromonas gingivalis is associated with rheumatoid arthritis as it expresses PAD, thereby promoting citrullination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. Name and describe the antibodies that are often detected in the diagnosis of rheumatoid arthritis.
A

Anti-cyclic citrullinated peptide antibodies – bind to peptides where arginine has been converted to citrulline, 95% specific, 60-70% sensitive
Rheumatoid factor – IgM antibody directed against Fc region of human IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. Describe B cell involvement in the pathophysiology of rheumatoid arthritis.
A

Type II – antibodies bind to citrullinated peptides leading to activation of macrophages, NK cells and complement
Type III – immune complexes form and get deposited leading to complement activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. Outline the roles of T cells in the pathophysiology of rheumatoid arthritis.
A

APCs present peptides to CD4+ T cells which then produce IFN-gamma and IL17
These cytokines act on fibroblasts and macrophages
This leads to the production of MMPs, IL1 and TNF-alpha

17
Q
  1. What happens to joints affected by rheumatoid arthritis?
A

The synovium becomes inflamed forming a pannus
This invades articular cartilage and adjacent bone
There is also an increased synovial fluid volume

18
Q
  1. What are antinuclear antibodies and how are they tested?
A

Group of antibodies against nuclear proteins

Tested by staining Hep-2 (human epidermoid cancer line) cells

19
Q
  1. List some genetic defects that may predispose to the development of SLE.
A

Abnormalities in clearing apoptotic cells (polymorphisms in complement, MBL and CRP)
Abnormalities in cellular activation (polymorphisms in genes encoding cytokines, chemokines, co-stimulatory molecules and intracellular signalling molecules)
B cell hyperactivity and loss of tolerance
Antibodies directed against particular intracellular proteins (could bind to nuclear or cytoplasmic antigens)

20
Q
  1. What are the two types of ANA and how can they be distinguished?
A

Anti-dsDNA – homogenous staining pattern, they are highly specific for SLE and high titres are associated with severe disease (useful for disease monitoring)
Anti-ENA4 (extractable nuclear antigens such as ribonucleoproteins (e.g. Ro, La, Sm))

21
Q
  1. Which disease are anti-Ro and anti-La antibodies characteristically found in?
A

Sjogren’s syndrome

22
Q
  1. List some other autoantibodies that are implicated in autoimmune disease.
A

Scl70, RNA polymerase, fibrillarin – diffuse cutaneous systemic sclerosis
Mi2, SRP – idiopathic inflammatory myopathies

23
Q
  1. Other than dsDNA, which other quantifiable component can be measured as a surrogate marker for disease activity in SLE?
A

C3 and C4 – C4 will decrease before C3

NOTE: we measure unactivated complement proteins

24
Q
  1. What triad defines antiphospholipid syndrome?
A

Recurrent venous or arterial thrombosis
Recurrent miscarriage
Thrombocytopaenia

25
Q
  1. Which antibodies are tested for in antiphospholipid syndrome?
A

Anti-cardiolipin antibody – immunoglobulins directed against phospholipids and 2 glycoprotein-1
Lupus anticoagulant – prolongation of phospholipid-dependent coagulation tests.
antiB2 glycoprotein

26
Q
  1. Outline the pathophysiology of systemic sclerosis.
A

Cytokines release by Th2 and Th17 leads to activation of fibroblasts and the development of fibrosis

27
Q
  1. What are the main features of limited cutaneous systemic sclerosis?
A
Skin involvement does not extend beyond the forearms 
Calcinosis
Raynaud’s phenomenon
Esophageal dysmotility
Sclerodactyly
Telangiectasia
28
Q
  1. What are the main features of diffuse cutaneous systemic sclerosis?
A
Skin involvement extends beyond the forearms 
CREST features 
More extensive gastrointestinal disease 
Interstitial pulmonary disease 
Renal cysts
29
Q
  1. Which antibodies are seen in limited and diffuse cutaneous systemic sclerosis?
A

Limited – anti-centromere

Diffuse – anti-topoisomerase 2 (aka anti-Scl70)

30
Q
  1. Describe the differences between the histology of dermatomyositis and polymyositis.
A

Dermatomyositis – perivascular CD4+ T cell and B cells are seen, this can cause an immune complex-mediated vasculitis (type III response)
Polymyositis – CD8+ T cells surround HLA Class I expressing myofibres, CD8+ T cells kill these myofibres via granzyme/perforin (type IV response)

31
Q
  1. Which antibodies are seen in dermatomyositis and polymyositis?
A

Dermatomyositis: anti-aminoacyl tRNA synthetase (e.g. Jo-1), anti-Mi2
Polymyositis: anti-signal recognition peptide antibody
NOTE: anti-aminoacyl tRNA synthetase antibody is cytoplasmic

32
Q
  1. Which small vessel vasculitides are associated with ANCA?
A

Microscopic polyangiitis (pANCA)
Churg-Strauss syndrome (pANCA) eosinophilc with granlomatous polyangitis
Granulomatosis with polyangiitis (cANCA) -wegners

33
Q
  1. Outline the pathophysiology of ANCA.
A

These antibodies are specific to antigens located within primary granules within the cytoplasm of neutrophils
Inflammation may lead to expression of these antigens on the surface of neutrophils
Antibody engagement with these antigens may lead to neutrophil activation (type II hypersensitivity)

34
Q
  1. Describe the key difference between cANCA and pANCA.
A

cANCA
• Cytoplasmic fluorescence
• Associated with antibodies against proteinase 3
• Occurs in > 90% of Wegener’s patients with renal involvement
pANCA
• Perinuclear staining pattern
• Associated with antibodies to myeloperoxidase
• Less sensitive and specific than cANCA
• Associated with MPA and Churg-Strauss syndrome